Work

Predicting response to epigenetic therapy

Year: 2014
Type: review
Abstract: Drugs targeting the epigenome are new promising cancer treatment modalities; however, not all patients receive the same benefit from these drugs. In contrast to conventional chemotherapy, responses may take several months after the initiation of treatment to occur. Accordingly, identification of good pretreatment predictors of response is of great value. Many clinical parameters and molecular targets have been tested in preclinical and clinical studies with varying results, leaving room for optimization. Here we provide an overview of markers that may predict the efficacy of FDA- and EMA-approved epigenetic drugs.
Language: English
Open Access status: bronze
OpenAlex ID: W2141456042
FWCI: 1.068
Cites: 90
Cited by: 103
Related to: 9